ArticleCureus2026
Return to Work Within 104 Weeks in Working-Age Patients Following Total Hip Arthroplasty.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Total hip arthroplasty (THA) is increasingly performed in working-age adults, making return-to-work (RTW) an important outcome. In the Netherlands, RTW is particularly relevant due to the legal obligation for employers to cover up to two-years of sick leave. While short-term RTW outcomes after THA have been described, evidence on long-term RTW and its determinants remains limited. This study evaluated RTW up to two-years after THA and explored clinical, occupational, and sociodemographic factors associated with RTW. Methods This single-center cohort study included patients aged 18-65 years who underwent primary THA between January 2016 and February 2018 at Zuyderland Medical Center (Sittard-Geleen, the Netherlands). Eligible patients were invited to complete a questionnaire on employment status, RTW timing, occupational characteristics, expectations, and perceived facilitators and barriers, alongside patient-reported outcome measures (PROMs: Oxford Hip Score and EuroQol Five Dimensions (EQ-5D)). Descriptive analyses were performed, and multivariable logistic regression was used to identify predictors of RTW. Time to RTW was analyzed using reversed Kaplan-Meier curves. Results Of 381 eligible patients, 182 responded (53.8%), and 145 completed all questionnaires (mean age 58.7 ± 5.6 years; 51% female). Preoperatively, 66% were employed and 6% self-employed. Full RTW was achieved by 77% of employed and 78% of self-employed patients, with a mean time to RTW of 7.4 ± 4.4 weeks. Most patients RTW within 12-weeks, with additional RTW occurring up to 52-weeks postoperatively. Full RTW was most common in administrative, managerial, and care-related occupations, whereas physically demanding jobs more often required modified duties or reduced hours. Social support at work and job satisfaction were the most frequently reported facilitators of RTW, while physical complaints and high physical workload were the main barriers. In multivariable analysis (n = 106), female sex was the only independent predictor of non-RTW (odds ratio (OR) 3.74, 95% confidence interval (CI) 1.29-10.84, p = 0.015). Other clinical and occupational factors were not significantly associated with RTW. Conclusion The majority of working-age patients returned to work within 12-weeks after THA and remained employed for two years. Female sex was independently associated with a lower likelihood of RTW. Enhanced occupational guidance, workplace adjustments, and targeted support may further optimize sustainable work reintegration after THA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.